Capps Kathleen S.
SEC CIK 2085127 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | See Remarks | 8,377 | — | $7,486 | 4 | 2025-11-25 | 2025-12-05 |
Most active insiders at ENTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Luly Jay R. | Pres, CEO, Dir | — | $67.5K |
| 2 | Or Yat Sun | CSO | — | $34.0K |
| 3 | Kieffer Tara Lynn | Chief Product Strategy Off | — | $30.0K |
| 4 | Luu Brendan | Chief Business Off | — | $19.8K |
| 5 | Trout Harry R. III | See Remarks | — | $13.0K |
| 6 | Rottinghaus Scott T. | Chief Medical Off | — | $11.4K |
| 7 | Capps Kathleen S. | See Remarks | — | $7,486 |
| 8 | Kowalsky Matthew Paul | CLO | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-05 | 2025-12-05 | ENTA | ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | S - Sale | $14.23 | -323 | 8,377 | -4% | -$4,596 | |
| 2025-12-03 | 2025-12-02 | ENTA | ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | S - Sale | $13.96 | -207 | 8,700 | -2% | -$2,890 | |
| 2025-12-03 | 2025-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | F - Tax | $14.12 | -85 | 8,907 | -0.9% | -$1,200 | |
| D | 2025-11-26 | 2025-11-25 | ENTA | ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | A - Grant | $0.00 | +3,163 | 8,992 | +54% | $0 |
Purchase Sale Sale after option exercise All abbreviations